August 8th, 2025: Novo Nordisk Expands Trademark Actions Against Compounded Ozempic Sellers Novo Nordisk has escalated its efforts to protect the Ozempic trademark, filing 14 new federal lawsuits against pharmacies, telehealth providers, and other sellers offering compounded semaglutide products
2014;9:e102620
Fat Loss and Body Composition Another benefit of IGF-1 LR3 is its ability to support fat loss while preserving muscle mass
The FDA updated its drug shortage list on Friday, marking the branded versions of semaglutide as fully available
[11] [12] Women of childbearing potential should be aware that tirzepatide may reduce the effectiveness of oral contraceptives, particularly during the first 4 weeks after initiation and after each dose escalation
Administered through subcutaneous injection, it is marketed under various brand names, including Ozempic and Wegovy